© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
July 02, 2020
The University of Southern California expert discusses next steps for the trial and how the recent results could impact the future of care for patients with prostate cancer.
May 30, 2020
Baseline CTC counts were shown to be strong indicators for subsequent therapy response and 2-year progression-free survival.